首页> 美国卫生研究院文献>Cell Death Disease >Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts decreasing the incidence of rejection episodes
【2h】

Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts decreasing the incidence of rejection episodes

机译:缺血预处理可诱导脂肪肝移植人类受体的自噬并限制坏死从而降低排斥反应的发生率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Whether ischemic preconditioning (IP) reduces ischemia/reperfusion (I/R) injury in human normal and fatty livers remains controversial. We compared two independent groups of liver donor transplants with versus without steatosis to evaluate IP consequences. Liver donors with (n=22) or without (n=28) steatosis either did or did not undergo IP before graft retrieval. Clinical data from the recipients, as well as histological and immunohistological characteristics of post-reperfusion biopsies were analyzed. Incidence of post-reperfusion necrosis was increased (10/10 versus 9/14, respectively; P<0.05) and the clinical outcome of recipients was worse for non-IP steatotic liver grafts compared with non-IP non-steatotic grafts. IP significantly lowered the transaminase values only in patients receiving a non-steatotic liver. An increased expression of beclin-1 and LC3, two pro-autophagic proteins, tended to decrease the incidence of necrosis (P=0.067) in IP steatotic livers compared with non-IP steatotic group. IP decreased the incidence of acute and chronic rejection episodes in steatotic livers (2/12 versus 6/10; P=0.07 and 2/12 versus 7/10; P<0.05, respectively), but not in non-steatotic livers. Thus, IP may induce autophagy in human steatotic liver grafts and reduce rejection in their recipients.
机译:缺血预处理(IP)是否能减轻人正常和脂肪肝的缺血/再灌注(I / R)损伤仍存在争议。我们比较了两组独立的有脂肪变性或无脂肪变性的肝供体移植,以评估IP后果。有(n = 22)或没有(n = 28)脂肪变性的肝供体在移植物取回之前已接受或未接受IP。分析了来自受体的临床数据以及再灌注后活检的组织学和免疫组织学特征。再灌注后坏死的发生率增加(分别为10/10与9/14; P <0.05),与非IP非脂肪变性肝移植相比,非IP脂肪变性肝移植患者的临床结局更差。 IP仅在接受非脂肪变性肝的患者中显着降低转氨酶值。与非IP脂肪变性组相比,IP脂肪变性肝脏中两种前自噬蛋白beclin-1和LC3的表达增加倾向于降低坏死的发生率(P = 0.067)。 IP降低了脂肪变性肝脏中急性和慢性排斥反应的发生率(分别为2/12对6/10; P = 0.07和2/12对7/10; P <0.05),但在非脂肪变性肝中没有。因此,IP可诱导人脂肪变性肝移植物中的自噬并减少其受体的排斥反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号